Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

T-cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global T-cell therapy market is expected to exhibit a CAGR of 16.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

T-cell therapy is an immunotherapy approach, known as adoptive cell transfer (ACT), wherein the immune cells from the body of the patient are utilized to treat cancer. It involves collecting T-cells via apheresis and re-engineering them in a laboratory. These re-engineered cells are then multiplied and infused into the body to recognize and kill cancer cells with targeted antigens on their surface. Presently, a growing number of T-cell therapies are undergoing clinical studies. One such study includes the development of an off-the-shelf approach that collects immune cells from healthy donors and makes them available for immediate use.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

The growing consumption of tobacco products, unhealthy dietary patterns and sedentary lifestyles are among the key factors escalating the risk of developing cancer. This, in confluence with the rising number of individuals diagnosed with bone marrow and blood-forming tissue diseases, represents one of the major factors catalyzing the demand for T-cell therapies. Moreover, the mass spread of coronavirus disease (COVID-19) has encouraged researchers worldwide to adopt T-cell therapies for treating high-risk patients. Apart from this, the rising awareness among individuals about medical services, in confluence with favorable government policies and regulations, is also propelling the market growth. Additionally, the United States Food and Drug Administration (USFDA) recently approved T-cell therapies to treat children with acute lymphoblastic leukemia (ALL) and adults with advanced lymphomas. This, in turn, is anticipated to provide lucrative opportunities to manufacturers and stimulate the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global T-cell therapy market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on modality, therapy type and indication.

Breakup by Modality:

  • Research
  • Commercialized
     

Breakup by Therapy Type:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • CAR T-cell based
  • T Cell Receptor (TCR) based
  • Tumor Infiltrating Lymphocytes (TIL) based
     

Breakup by Indication:

  • Hematologic Malignancies
    • Lymphoma
    • Leukemia
    • Myeloma
  • Solid Tumors
    • Melanoma
    • Brain and Central Nervous System
    • Liver Cancer
    • Others
  • Others
     

Breakup by Region:

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Aurora Biopharma Inc., bluebird bio Inc, Bristol-Myers Squibb Company, Fate Therapeutics, Gilead Sciences Inc., Merck KGaA, Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Pfizer Inc., Sorrento Therapeutics Inc. and TCR2 Therapeutics.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Modality, Therapy Type, Indication, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., Aurora Biopharma Inc., bluebird bio Inc, Bristol-Myers Squibb Company, Fate Therapeutics, Gilead Sciences Inc., Merck KGaA, Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Pfizer Inc., Sorrento Therapeutics Inc. and TCR2 Therapeutics
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global T-cell Therapy Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Modality
    6.1    Research
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Commercialized
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Therapy Type
    7.1    CAR T-cell based
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    T Cell Receptor (TCR) based
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Tumor Infiltrating Lymphocytes (TIL) based
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Indication
    8.1    Hematologic Malignancies
        8.1.1 Market Trends
        8.1.2 Key Segments
           8.1.2.1 Lymphoma
           8.1.2.2 Leukemia
           8.1.2.3 Myeloma
        8.1.3 Market Forecast
    8.2    Solid Tumors
        8.2.1 Market Trends
        8.2.2 Key Segments
           8.2.2.1 Melanoma
           8.2.2.2 Brain and Central Nervous System
           8.2.2.3 Liver Cancer
           8.2.2.4 Others
        8.2.3 Market Forecast
    8.3   Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Amgen Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Aurora Biopharma Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    bluebird bio Inc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bristol-Myers Squibb Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Fate Therapeutics
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Gilead Sciences Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Merck KGaA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Mustang Bio Inc. (Fortress Biotech Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Novartis AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Pfizer Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Sorrento Therapeutics Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    TCR2 Therapeutics
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials

List of Figures

Figure 1: Global: T-cell Therapy Market: Major Drivers and Challenges
Figure 2: Global: T-cell Therapy Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: T-cell Therapy Market: Breakup by Modality (in %), 2021
Figure 5: Global: T-cell Therapy Market: Breakup by Therapy Type (in %), 2021
Figure 6: Global: T-cell Therapy Market: Breakup by Indication (in %), 2021
Figure 7: Global: T-cell Therapy Market: Breakup by Region (in %), 2021
Figure 8: Global: T-cell Therapy (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: T-cell Therapy (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: T-cell Therapy (Commercialized) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: T-cell Therapy (Commercialized) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: T-cell Therapy (CAR T-cell based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: T-cell Therapy (CAR T-cell based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: T-cell Therapy (T Cell Receptor-TCR based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: T-cell Therapy (T Cell Receptor-TCR based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: T-cell Therapy (Tumor Infiltrating Lymphocytes-TIL based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: T-cell Therapy (Tumor Infiltrating Lymphocytes-TIL based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: T-cell Therapy (Hematologic Malignancies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: T-cell Therapy (Hematologic Malignancies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: T-cell Therapy (Solid Tumors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: T-cell Therapy (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: T-cell Therapy (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: T-cell Therapy (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: T-cell Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: T-cell Therapy Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: T-cell Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: T-cell Therapy Industry: SWOT Analysis
Figure 74: Global: T-cell Therapy Industry: Value Chain Analysis
Figure 75: Global: T-cell Therapy Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: T-cell Therapy Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: T-cell Therapy Market Forecast: Breakup by Modality (in Million US$), 2022-2027
Table 3: Global: T-cell Therapy Market Forecast: Breakup by Therapy Type (in Million US$), 2022-2027
Table 4: Global: T-cell Therapy Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 5: Global: T-cell Therapy Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: T-cell Therapy Market: Competitive Structure
Table 7: Global: T-cell Therapy Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

We expect the global T-cell therapy market to exhibit a CAGR of 16.90% during 2022-2027.

The rising prevalence of cancer, coupled with continuous advancements in the field of oncology, are
currently driving the global T-cell therapy market.

The sudden outbreak of the COVID-19 pandemic has led to increasing number of clinical trials to
introduce novel T-cell therapy for treating high-risk COVID-19 patients, thereby positively influencing the
market growth.

Based on the modality, the global T-cell therapy market can be segmented into research and
commercialized. Currently, research holds the majority of the total market share.

Based on the therapy type, the global T-cell therapy market has been divided into CAR T-cell based, T
Cell Receptor (TCR) based, and Tumor Infiltrating Lymphocytes (TIL) based. Among these, CAR T-cell
based therapy currently exhibits a clear dominance in the market.

Based on the indication, the global T-cell therapy market can be categorized into hematologic
malignancies, solid tumors, and others. Currently, hematologic malignancies account for the largest
market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global T-cell therapy market include Amgen Inc., Aurora Biopharma
Inc., bluebird bio Inc, Bristol-Myers Squibb Company, Fate Therapeutics, Gilead Sciences Inc., Merck
KGaA, Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Pfizer Inc., Sorrento Therapeutics Inc., and
TCR2 Therapeutics.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links